MedTrace Logo

FATIMA Trial: EGCG and Vitamin D3 for Prevention of Fibroid Recurrence

NCT07647198 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2026-06-16

No results posted yet for this study

Summary

The aim of this randomized controlled clinical trial is to evaluate the efficacy of green tea (EGCG) and vitamin D3 supplementation in preventing uterine fibroid recurrence following fibroid removal.

Conditions

  • Uterine Fibroids (Leiomyoma)

Interventions

COMBINATION_PRODUCT

Vitamin D and Green Tea

EGCG and Vitamin D3 (300 mg, 2000 IU respectively, in tablets Each tablet will contain 150 mg EGCG, 1000 IU Vitamin D

OTHER

Placebo

The placebo has no medication and the participant will receive standard of care.

Sponsors & Collaborators

  • Sheikh Shakhbout Medical City

    lead OTHER

Principal Investigators

  • Ayman Al Hendy, M.D. Ph.D. · Sheikh Shakbhout Medical City

  • Basel Imam, M.D. · Sheikh Shakbhout Medical City

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-22
Primary Completion
2029-08-22
Completion
2029-12-22

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07647198 on ClinicalTrials.gov